Luspatercept for beta-thalassemia – A new horizon?
European Oncology and Haematology
Several treatment options are being explored to reduce the transfusion burden and improve quality of life for patients with beta-thalassemia. One such prospect is the drug luspatercept, which has recently been approved for use in the USA for the treatment of beta-thalassemia. However, socioeconomic factors may act as a barrier to its widespread use.
Ammad Ud Din, Mohammad and Anwer, Faiz, "Luspatercept for beta-thalassemia – A new horizon?" (2020). Rochester Regional Health authored publications and proceedings. 150.